Cited 5 time in
Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jangid, Ashok Kumar | - |
| dc.contributor.author | Noh, Kyung Mu | - |
| dc.contributor.author | Kim, Sungjun | - |
| dc.contributor.author | Kim, Kyobum | - |
| dc.date.accessioned | 2024-08-08T12:31:24Z | - |
| dc.date.available | 2024-08-08T12:31:24Z | - |
| dc.date.issued | 2024-09 | - |
| dc.identifier.issn | 0144-8617 | - |
| dc.identifier.issn | 1879-1344 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/22132 | - |
| dc.description.abstract | Modified biopolymers that are based on prebiotics have been found to significantly contribute to immunomodulatory events. In recent years, there has been a growing use of modified biomaterials and polymer-functionalized nanomaterials in the treatment of various tumors by activating immune cells. However, the effectiveness of immune cells against tumors is hindered by several biological barriers, which highlights the importance of harnessing prebiotic-based biopolymers to enhance host defenses against cancer, thus advancing cancer prevention strategies. Inulin, in particular, plays a crucial role in activating immune cells and promoting the secretion of cytokines. Therefore, this mini-review aims to emphasize the importance of inulin in immunomodulatory responses, the development of inulin-based hybrid biopolymers, and the role of inulin in enhancing immunity and modifying cell surfaces. Furthermore, we discuss the various approaches of chemical modification for inulin and their potential use in cancer treatment, particularly in the field of cancer immunotherapy. © 2024 Elsevier Ltd | - |
| dc.format.extent | 20 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier Ltd | - |
| dc.title | Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.carbpol.2024.122311 | - |
| dc.identifier.scopusid | 2-s2.0-85194192820 | - |
| dc.identifier.wosid | 001246570400001 | - |
| dc.identifier.bibliographicCitation | Carbohydrate Polymers, v.340, pp 1 - 20 | - |
| dc.citation.title | Carbohydrate Polymers | - |
| dc.citation.volume | 340 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 20 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalResearchArea | Polymer Science | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
| dc.relation.journalWebOfScienceCategory | Polymer Science | - |
| dc.subject.keywordPlus | HYDROPHOBICALLY-MODIFIED INULIN | - |
| dc.subject.keywordPlus | CHAIN FATTY-ACIDS | - |
| dc.subject.keywordPlus | DELIVERY-SYSTEM | - |
| dc.subject.keywordPlus | GUT MICROBIOTA | - |
| dc.subject.keywordPlus | DRUG-DELIVERY | - |
| dc.subject.keywordPlus | DELTA INULIN | - |
| dc.subject.keywordPlus | T-CELLS | - |
| dc.subject.keywordPlus | POLYMERIC MICELLES | - |
| dc.subject.keywordPlus | INTERACTION FORCES | - |
| dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
| dc.subject.keywordAuthor | Fructan | - |
| dc.subject.keywordAuthor | Hybrid biopolymers | - |
| dc.subject.keywordAuthor | Immunomodulatory responses | - |
| dc.subject.keywordAuthor | Inulin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
